Charles Schwab Investment Management Inc. Sells 492 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Charles Schwab Investment Management Inc. decreased its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 0.4% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 139,001 shares of the medical instruments supplier’s stock after selling 492 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.66% of Mettler-Toledo International worth $208,460,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of MTD. Family Firm Inc. purchased a new stake in Mettler-Toledo International in the 2nd quarter worth $25,000. Blue Trust Inc. boosted its stake in Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 17 shares during the last quarter. Ashton Thomas Securities LLC purchased a new position in Mettler-Toledo International during the 3rd quarter valued at approximately $37,000. Rothschild Investment LLC bought a new stake in Mettler-Toledo International in the 2nd quarter worth approximately $42,000. Finally, Itau Unibanco Holding S.A. purchased a new stake in shares of Mettler-Toledo International during the 2nd quarter worth approximately $42,000. 95.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Stifel Nicolaus reduced their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Evercore ISI upped their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company dropped their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research report on Monday, November 11th. Robert W. Baird decreased their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research report on Monday, November 11th. Finally, JPMorgan Chase & Co. raised their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, Mettler-Toledo International currently has a consensus rating of “Hold” and an average price target of $1,338.75.

Insider Activity at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the transaction, the director now directly owns 240 shares of the company’s stock, valued at approximately $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Stock Performance

MTD opened at $1,217.97 on Friday. The stock’s 50 day moving average price is $1,361.85 and its 200-day moving average price is $1,398.96. Mettler-Toledo International Inc. has a one year low of $1,059.08 and a one year high of $1,546.93. The stock has a market cap of $25.70 billion, a price-to-earnings ratio of 32.84, a P/E/G ratio of 3.95 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million for the quarter, compared to the consensus estimate of $941.93 million. As a group, analysts predict that Mettler-Toledo International Inc. will post 40.39 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.